Matches in Nanopublications for { ?s ?p "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP306688.RAXbq6Sx_nNd9fPwTuVLskVQoYyBKGa8RcmF3kEQbpxwE130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP306688.RAXbq6Sx_nNd9fPwTuVLskVQoYyBKGa8RcmF3kEQbpxwE130_provenance.
- assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1130042.RAWzJj3wp4NfPemqb6GDDfWKUUPQuznvuwQnzZGkMdYHo130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130042.RAWzJj3wp4NfPemqb6GDDfWKUUPQuznvuwQnzZGkMdYHo130_provenance.
- NP304334.RA8Bakhd5YDMyT8ItsTF1MSAhji9gfaBuh3MBvjOBLg9Q130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP304334.RA8Bakhd5YDMyT8ItsTF1MSAhji9gfaBuh3MBvjOBLg9Q130_provenance.
- NP527153.RA8UTMTPGqN-rQ-IpzOOfSOkGv3dHZQMMykc5NJKcg9qE130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP527153.RA8UTMTPGqN-rQ-IpzOOfSOkGv3dHZQMMykc5NJKcg9qE130_provenance.
- NP528143.RA04wmK8K5ESAA30_5LQUgoWjEETRHz_fWgfUeWRNzvL8130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP528143.RA04wmK8K5ESAA30_5LQUgoWjEETRHz_fWgfUeWRNzvL8130_provenance.
- NP1130040.RAzQuw_rX0yue3YbW8LBwRzZJ1OecRkrIlBO_RxfVn9kg130_assertion description "[KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1130040.RAzQuw_rX0yue3YbW8LBwRzZJ1OecRkrIlBO_RxfVn9kg130_provenance.